Alantra advises Holtzbrinck Digital on the sale of Labguru to Battery Ventures
SECTORHealthcare
ServiceM&A
New York – Alantra advises Holtzbrinck Digital on the sale of Labguru, a leading lab informatics vendor, to Battery Ventures (“Battery”), a global technology-focused investment firm.
Founded in 2007, Labguru has developed a cloud-based data management platform combining an Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and informatics tools to provide a complete solution for the life science industry.
Battery Ventures was founded in 1983 and partners with founders and management teams, developing category-defining businesses in markets including software & services, enterprise infrastructure, healthcare IT, and more. The firm backs companies at all stages, ranging from seed and early to growth and buyout.
“It was a true privilege to work with the talented team at Labguru and Holtzbrinck and advise on a transaction that has the potential to redefine the lab informatics industry. We wish Labguru and Titian all the best in their mission of automating as many research and development workflow components as possible so that scientists can devote themselves fully to discovering new groundbreaking therapies.” said Frederic Laurier, Managing Director and Head of Healthcare Technology at Alantra.
“We are greatly pleased with the guidance and expertise provided by Alantra in facilitating this transaction. Their profound understanding of the market dynamics and strategic advice were invaluable in securing a successful acquisition by Battery Ventures” said Marc-Orell Dedorath, Head of Group M&A at Holtzbrinck. Ariel Yarnitsky, CEO of Labguru, added: “This partnership marks a significant step forward in our mission to innovate and lead in the lab management space. We are confident that together with Battery Ventures and Titian Software, Labguru will continue to transform the landscape of life sciences research and development.”
Labguru will join Battery’s Titian Software to create a global organization that offers an end-to-end solution across life sciences and laboratory applications from research to production, spanning the entire workflow from ELN to inventory and sample management, research, testing, and QC.
Related Transactions
-
Oct 2024Sell-side advisoryOct 2024SECTOR HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Aug 2024Sell-side AdvisoryAug 2024SECTOR HealthcareService M&A